[1] 柴颖, 郭宁, 么焕新, 等. 幽门螺杆菌根除治疗对非酒精性脂肪性肝病脂代谢及胰岛素抵抗的影响. 中华医院感染学杂志, 2021, 31(9):1319-1323. [2] Kamangar F, Sheikhattari P, Mohebtash M. Helicobacter pylori and its effect on human health and disease. Arch Iran Med, 2011, 14(3):192-199. [3] 唐君瑞, 李明珂, 曹光琼, 等. 非酒精性脂肪性肝病与幽门螺杆菌感染的相关性. 疑难病杂志, 2020, 19(3):242-247. [4] 朱蓓蓓, 周鸿科, 柏晓芬, 等. Hp感染与非酒精性脂肪性肝病关系的研究进展. 海南医学, 2017, 28(11):1833-1835. [5] 孙婉璐, 曹海霞, 范建高. 非酒精性脂肪性肝病的诊断与治疗. 中华肝脏病杂志, 2014, 22(9):705-707. [6] 中华医学会消化病学分会幽门螺杆菌学组/全国幽门螺杆菌研究协作组, 刘文忠, 谢勇, 等. 第四次全国幽门螺杆菌感染处理共识报告. 中华消化杂志, 2012, 32(10):655-661. [7] 董九龙, 徐新娟. 根除幽门螺杆菌对非酒精性脂肪肝病伴幽门螺杆菌感染治疗的影响. 现代医学, 2016, 44(2):198-201. [8] 侯莉, 吴莺. 镇江地区非酒精性脂肪性肝病患病情况及与幽门螺杆菌感染的相关性. 中国老年学杂志, 2018, 38(4):844-845. [9] 张玲, 高峰. 非酒精性脂肪性肝病与幽门螺杆菌感染的相关性. 中华消化杂志, 2017, 37(1):43-45. [10] Tang DM, Kumar S. The association between Helicobacter pylori Infection and Nonalcoholic Fatty Liver Disease. Cuee Gastroenterol Rep, 2017, 19(2):5-5. [11] 张园园, 周希乔. 肠道菌群与非酒精性脂肪肝研究进展.中华消化杂志, 2016, 36(11):790-792. [12] 郭晓燕, 史海涛, 师阿盟, 等. 非酒精性脂肪性肝病患者幽门螺杆菌感染状况调查. 实用肝脏病杂志, 2013, 16(5):451-453. [13] He C, Yang Z, Lu NH. Helicobacter pylori infection and diabete: is it a myth or fact?. World J Gastroenterol, 2014, 20(16):4607-4617. [14] Kim DJ, Park JH, Franchi L, et al. The Cag pathogenicity island and interaction between TLR2/NOD2 and NLRP3 regulate IL-1β production in Heficobacter pylori infected dendritic cells. European Journal of Immunology, 2013, 43(10):2650-2658. [15] Malamug LR, Karnchanasorn R, Sama R, et al. The role of Helicobacter pylori seropositivity in insulin sensitivity, beta cell function, and abnormal glucose tolerance. Scientifica, 2014, 2014(160):870165. [16] Waluga M, Kukla M, Zorniak M, et al. From the stomach to other organs: Helicobacter pylori and the liver. World J Hepatol, 2015, 7(18):2136-2146. |